The effect of montelukast therapy on mRNA profile of matrix metalloproteinases and their inhibitors in the sputum of patients with asthma

Project Details

StatusFinished
Effective start/end date1/03/0931/03/12

Funding

  • Merck Sharp & Dohme Ltd: £44,439.00